Sign in
IVEVF Stock Price, Chart, Stats & News
Inventiva S.A.
Save
Inventiva S.A. (IVEVF) does not currently pay a dividend.
760.63M
Market cap
–
Current P/E
–
Forward P/E
IVEVF chart
About
Health care
Sector
Biotechnology
Industry
Inventiva S. A. is a clinical-stage biopharmaceutical company focused on developing oral small molecule therapies for conditions such as non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and various other diseases. Its leading drug candidate, Lanifibranor, has successfully completed Phase IIb clinical trials for NASH treatment.
Similar securities
Based on sector and market capitalization
Report issue